Reshma Rangwala's most recent trade in Karyopharm Therapeutics Inc was a trade of 5,066 Common Stock done at an average price of $9.4 . Disclosure was reported to the exchange on March 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc | Reshma Rangwala | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 9.41 per share. | 02 Mar 2026 | 5,066 | 56,739 (0%) | 0% | 9.4 | 47,669 | Common Stock |
| Karyopharm Therapeutics Inc | Reshma Rangwala | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2026 | 32,415 | 61,805 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Reshma Rangwala | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2025 | 945 | 29,798 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Reshma Rangwala | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.43 per share. | 12 Sep 2025 | 408 | 29,390 (0%) | 0% | 6.4 | 2,623 | Common Stock |
| Karyopharm Therapeutics Inc | Reshma Rangwala | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.17 per share. | 23 Apr 2025 | 419 | 28,853 (0%) | 0% | 6.2 | 2,585 | Common Stock |
| Karyopharm Therapeutics Inc | Reshma Rangwala | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.29 per share. | 04 Mar 2025 | 3,587 | 29,272 (0%) | 0% | 6.3 | 22,562 | Common Stock |
| Karyopharm Therapeutics Inc | Reshma Rangwala | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 10,833 | 10,833 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Reshma Rangwala | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 9,166 | 9,166 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Reshma Rangwala | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 5,416 | 28,276 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Reshma Rangwala | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 4,583 | 32,859 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Reshma Rangwala | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 22 Apr 2024 | 6,789 | 342,931 (0%) | 0% | 1.2 | 7,943 | Common Stock |
| Karyopharm Therapeutics Inc | Reshma Rangwala | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 29 Feb 2024 | 15,667 | 355,689 (0%) | 0% | 1.2 | 18,330 | Common |
| Karyopharm Therapeutics Inc | Reshma Rangwala | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 29 Feb 2024 | 5,969 | 349,720 (0%) | 0% | 1.2 | 7,163 | Common |
| Karyopharm Therapeutics Inc | Rangwala Reshma | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 198,959 | 371,356 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Rangwala Reshma | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 14,167 | 172,397 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Reshma Rangwala | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.05 per share. | 20 Apr 2023 | 6,655 | 158,230 (0%) | 0% | 4.1 | 26,953 | Common Stock |
| Karyopharm Therapeutics Inc | Reshma Rangwala | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.03 per share. | 20 Apr 2023 | 115 | 164,885 (0%) | 0% | 4.0 | 463 | Common Stock |
| Karyopharm Therapeutics Inc | Reshma Rangwala | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 100,000 | 165,000 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Reshma Rangwala | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Reshma Rangwala | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 65,000 | 65,000 (0%) | 0% | 0 | Common Stock | |
| Aravive Inc | Reshma Rangwala | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 175,000 | 175,000 | - | - | Stock Option (Right to buy) |